Suppressive therapy for recurrent cutaneous herpes infections in children under 12 years: An observational study
- PMID: 34704300
- DOI: 10.1111/apa.16165
Suppressive therapy for recurrent cutaneous herpes infections in children under 12 years: An observational study
References
REFERENCES
-
- Agence Nationale d'Accréditation et d'Evaluation en Santé. Prise en charge de l'herpès cutanéo-muqueux chez le sujet immuno-compétent (manifestations oculaires exclues). Presse Med. 2002;31:363-370.
-
- Tyring SK, Baker D, Snowden W. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir. J Infect Dis. 2002;186:S40-S46.
-
- Gittler JK, Mu EW, Orlow SJ. Characterization of Herpes Simplex Virus infections seen in the pediatric dermatology office. Pediatr Dermatol. 2017;34:446-449.
-
- Szinnai G, Schaad UB, Heininger U. Multiple herpetic whitlow lesions in a 4-year-old girl: case report and review of the literature. Eur J Pediatr. 2001;160:528-533.
-
- Pittet LF, Curtis N. Does oral antiviral suppressive therapy prevent recurrent herpes labialis in children? Arch Dis Child. 2019;104:916-919.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical